Company profile
Ambest Pharmaceutical (China) company profile
Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently holds the drug production approvals of monoammonium glycyrrhizinate and cysteine and sodium chloride injection and floium Ginkgo extract and tertram rthypyrazine sodium chloride injection.
Business identity
- Operating status
- Active
- Company type
- For Profit
Headquarters
- Headquarters
- Caoxi, Jiangxi, China
- Country code
- CN
- Continent
- Asia